No Data
No Data
Top Premarket Decliners
TFF Pharmaceuticals Announces Preclinical Data Published on TFF Technology
TFF Pharmaceuticals' Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery
TFF Pharmaceuticals Enters Pact for Dry Powder MRNA-based Covid Treatment
Express News | TFF Pharmaceuticals Announced Its New Partnership With Emory University And The Biomedical Advanced Research And Development Authority To Develop A Dry Powder Inhaled Mrna-based Treatment For Influenza And Covid
TFF Pharmaceuticals Announces Positive Preclinical Data From Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization
No Data
No Data